SCHEMBL30762949

SCHEMBL30762949

CCOC(=O)C(C)Oc1ccc2c(-c3c(F)cccc3F)cc(=O)oc2c1

nearest known ligand 0.65

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.65
▸ HPGD P15428 8/20 0.65
▸ KDM4E B2RXH2 6/20 0.56
▸ RECQL P46063 2/20 0.56
▸ HTT P42858 2/20 0.56
▸ LMNA P02545 1/20 0.56
▸ ALDH2 P05091 2/20 0.54
▸ AR P10275 2/20 0.52
▸ IGLV6-57 P01721 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.46
▸ MAPK1 P28482 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839119 1.00 ALDH1A1 (0.65) ALDH1A1HPGDKDM4ERECQLHTT
SCHEMBL30762856 0.90 ALDH1A1 (0.62) ALDH1A1HPGDKDM4ERECQLHTT
SCHEMBL20839368 0.90 ALDH1A1 (0.62) ALDH1A1HPGDKDM4ERECQLHTT
SCHEMBL20839404 0.88 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ERECQLHTT
SCHEMBL30762850 0.88 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ERECQLHTT
SCHEMBL26104548 0.87 ALDH1A1 (0.71) ALDH1A1HPGDKDM4ERECQLHTT
SCHEMBL21629554 0.86 ALDH1A1 (0.73) ALDH1A1HPGDKDM4ERECQLHTT
SCHEMBL21629565 0.84 ALDH1A1 (0.66) ALDH1A1HPGDKDM4ERECQLHTT
SCHEMBL31089529 0.84 ALDH1A1 (0.77) ALDH1A1HPGDKDM4ERECQLHTT
SCHEMBL21629555 0.84 ALDH1A1 (0.77) ALDH1A1HPGDKDM4ERECQLHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN claimed
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN disclosed
Send feedback